VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · IEX Real-Time Price · USD
0.710
+0.055 (8.40%)
At close: Jul 19, 2024, 12:00 AM
0.720
+0.010 (1.39%)
Pre-market: Jul 22, 2024, 9:08 AM EDT
VolitionRx Employees
VolitionRx had 110 employees as of December 31, 2023. The number of employees increased by 6 or 5.77% compared to the previous year.
Employees
110
Change (1Y)
6
Growth (1Y)
5.77%
Revenue / Employee
$7,246
Profits / Employee
-$317,336
Market Cap
58.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Enzo Biochem | 190 |
HOOKIPA Pharma | 179 |
Allakos | 131 |
Adlai Nortye | 127 |
Mural Oncology | 117 |
ProPhase Labs | 113 |
InspireMD | 66 |
VNRX News
- 13 days ago - Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing - PRNewsWire
- 25 days ago - VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting - PRNewsWire
- 5 weeks ago - Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 7 weeks ago - VolitionRx Limited to Present at Jefferies Global Healthcare Conference - PRNewsWire
- 2 months ago - VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update - PRNewsWire
- 2 months ago - VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update - PRNewsWire
- 3 months ago - Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech - PRNewsWire
- 4 months ago - VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update - PRNewsWire